Crossmark

Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir

Crossref DOI link: https://doi.org/10.1038/s10038-019-0685-2

Published Online: 2019-10-23

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matsumoto, Jun https://orcid.org/0000-0001-7224-108X
San, Su Nwe

Fujiyoshi, Masachika

Kawauchi, Ayano

Chiba, Natsumi

Tagai, Ran

Sanbe, Ryoko

Yanaka, Shiho

Sakaue, Hiroaki

Kato, Yoshinori

Nakamura, Hiroyoshi

Yamada, Harumi

Ariyoshi, Noritaka
Funding

Funding for this research was provided by:

MEXT | Japan Society for the Promotion of Science (16K18955)
License Information

Text and Data Mining valid from 2019-10-23

Version of Record valid from 2019-10-23
More Information

Article History

Received: 2 September 2019

Revised: 29 September 2019

Accepted: 2 October 2019

First Online: 23 October 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below